de Hingh IHJT - Search Results

1

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS. van Driel WJ, et al. Among authors: de hingh ihjt. N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. N Engl J Med. 2018. PMID: 29342393 Free article. Clinical Trial.

2

Preoperative biliary drainage for cancer of the head of the pancreas.

van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. van der Gaag NA, et al. N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230. N Engl J Med. 2010. PMID: 20071702 Free article. Clinical Trial.

3

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.

Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Klaver YL, et al. Br J Surg. 2010 Dec;97(12):1874-80. doi: 10.1002/bjs.7249. Epub 2010 Aug 30. Br J Surg. 2010. PMID: 20806291

4

Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications.

Dovern E, de Hingh IH, Verwaal VJ, van Driel WJ, Nienhuijs SW. Dovern E, et al. Eur J Gynaecol Oncol. 2010;31(3):256-61. Eur J Gynaecol Oncol. 2010. PMID: 21077465 Review.

5

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.

Klaver YL, de Hingh IH, Boot H, Verwaal VJ. Klaver YL, et al. J Surg Oncol. 2011 Apr;103(5):431-4. doi: 10.1002/jso.21836. Epub 2010 Dec 29. J Surg Oncol. 2011. PMID: 21400529

6

Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.

Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Klaver YL, et al. Ann Surg. 2011 Jul;254(1):125-30. doi: 10.1097/SLA.0b013e3182197102. Ann Surg. 2011. PMID: 21502859

7

Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.

Klaver YL, Chua TC, de Hingh IH, Morris DL. Klaver YL, et al. J Surg Oncol. 2012 Feb;105(2):113-8. doi: 10.1002/jso.22019. Epub 2011 Jul 20. J Surg Oncol. 2012. PMID: 21780124

8

Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.

Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Klaver YL, et al. Ann Surg Oncol. 2012 Jul;19 Suppl 3:S475-82. doi: 10.1245/s10434-011-1984-9. Epub 2011 Aug 12. Ann Surg Oncol. 2012. PMID: 21837528

9

Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.

Klaver YL, Leenders BJ, Creemers GJ, Rutten HJ, Verwaal VJ, Lemmens VE, de Hingh IH. Klaver YL, et al. Am J Clin Oncol. 2013 Apr;36(2):157-61. doi: 10.1097/COC.0b013e3182438c55. Am J Clin Oncol. 2013. PMID: 22314003

10

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.

Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IH, Punt CJ. Klaver YL, et al. Eur J Surg Oncol. 2012 Jul;38(7):617-23. doi: 10.1016/j.ejso.2012.03.008. Epub 2012 May 8. Eur J Surg Oncol. 2012. PMID: 22572106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page